Clinical Significance of TP53, BIRC3, ATM and MAPK-ERK genes in Chronic Lymphocytic Leukaemia: Data from the Randomised UK LRF CLL4 Trial
![Thumbnail](/bitstream/handle/internal/3476/46%20Blakemore%20Leukemia%202019%20accepted%20version.pdf.jpg?sequence=10&isAllowed=y)
View/ Open
ICR Author
Author
Else, M
Morilla, R
Catovsky, D
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Biology of Childhood Leukaemia
Language
eng
Date accepted
2019-12-05
License start date
2019-12-05
Citation
Leukemia